Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO, Director
-
Stock Symbol
-
EDIT on Nasdaq
There are no Buy or Sell transactions made by James C. Mullen since 9/17/2023
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
75.9K |
$827K |
$10.90 |
Jan 3, 2022 |
Direct |
|
|
| Stock Option (right to buy) |
171K |
|
|
Apr 14, 2022 |
Direct |
Common Stock |
|
Transactions reported by James C. Mullen for Editas Medicine, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.